서브메뉴
검색
Identifying Mechanisms of Drug Tolerance in EGFR Mutant Lung Cancer
Identifying Mechanisms of Drug Tolerance in EGFR Mutant Lung Cancer
상세정보
- 자료유형
- 학위논문파일 국외
- ISBN
- 9798534652116
- DDC
- 616.99
- 저자명
- Hu, Bomiao.
- 서명/저자
- Identifying Mechanisms of Drug Tolerance in EGFR Mutant Lung Cancer
- 발행사항
- [Sl] : Yale University, 2021
- 발행사항
- Ann Arbor : ProQuest Dissertations & Theses, 2021
- 형태사항
- 112 p
- 주기사항
- Source: Dissertations Abstracts International, Volume: 83-02, Section: B.
- 주기사항
- Advisor: Politi, Katerina.
- 학위논문주기
- Thesis (Ph.D.)--Yale University, 2021.
- 사용제한주기
- This item must not be sold to any third party vendors.
- 일반주제명
- Oncology
- 일반주제명
- Biology
- 일반주제명
- Pathology
- 일반주제명
- Cellular biology
- 일반주제명
- Therapy
- 일반주제명
- Genetics
- 일반주제명
- Metastasis
- 일반주제명
- Immunotherapy
- 일반주제명
- Cytotoxicity
- 일반주제명
- Disease
- 일반주제명
- Cancer therapies
- 일반주제명
- Mutation
- 일반주제명
- Families & family life
- 일반주제명
- Epigenetics
- 일반주제명
- Kinases
- 일반주제명
- Cell cycle
- 일반주제명
- Drug resistance
- 일반주제명
- Patients
- 일반주제명
- Medicine
- 일반주제명
- Medical prognosis
- 일반주제명
- Antigen presentation
- 일반주제명
- Surgery
- 일반주제명
- Graduate studies
- 일반주제명
- Immune system
- 일반주제명
- Medical research
- 일반주제명
- Clinical trials
- 일반주제명
- Tumors
- 일반주제명
- Cell growth
- 일반주제명
- Chemotherapy
- 키워드
- Drug tolerance
- 키워드
- Osimertinib
- 기타저자
- Yale University Experimental Pathology
- 기본자료저록
- Dissertations Abstracts International. 83-02B.
- 기본자료저록
- Dissertation Abstract International
- 전자적 위치 및 접속
- 로그인 후 원문을 볼 수 있습니다.
MARC
008220131s2021 us c eng d■020 ▼a9798534652116
■035 ▼a(MiAaPQ)AAI28320819
■040 ▼aMiAaPQ▼cMiAaPQ
■0820 ▼a616.99
■1001 ▼aHu, Bomiao.
■24510▼aIdentifying Mechanisms of Drug Tolerance in EGFR Mutant Lung Cancer
■260 ▼a[Sl]▼bYale University▼c2021
■260 1▼aAnn Arbor▼bProQuest Dissertations & Theses▼c2021
■300 ▼a112 p
■500 ▼aSource: Dissertations Abstracts International, Volume: 83-02, Section: B.
■500 ▼aAdvisor: Politi, Katerina.
■5021 ▼aThesis (Ph.D.)--Yale University, 2021.
■506 ▼aThis item must not be sold to any third party vendors.
■590 ▼aSchool code: 0265.
■650 4▼aOncology
■650 4▼aBiology
■650 4▼aPathology
■650 4▼aCellular biology
■650 4▼aTherapy
■650 4▼aGenetics
■650 4▼aMetastasis
■650 4▼aImmunotherapy
■650 4▼aCytotoxicity
■650 4▼aDisease
■650 4▼aCancer therapies
■650 4▼aMutation
■650 4▼aFamilies & family life
■650 4▼aEpigenetics
■650 4▼aKinases
■650 4▼aCell cycle
■650 4▼aDrug resistance
■650 4▼aPatients
■650 4▼aMedicine
■650 4▼aMedical prognosis
■650 4▼aAntigen presentation
■650 4▼aSurgery
■650 4▼aGraduate studies
■650 4▼aImmune system
■650 4▼aMedical research
■650 4▼aClinical trials
■650 4▼aTumors
■650 4▼aCell growth
■650 4▼aChemotherapy
■653 ▼aDrug tolerance
■653 ▼aEpidermal Growth Factor Receptor
■653 ▼aMutant lung cancer
■653 ▼aWhole-Exome Sequencing
■653 ▼aOsimertinib
■690 ▼a0992
■690 ▼a0306
■690 ▼a0571
■690 ▼a0379
■690 ▼a0212
■690 ▼a0369
■690 ▼a0564
■690 ▼a0576
■71020▼aYale University▼bExperimental Pathology.
■7730 ▼tDissertations Abstracts International▼g83-02B.
■773 ▼tDissertation Abstract International
■790 ▼a0265
■791 ▼aPh.D.
■792 ▼a2021
■793 ▼aEnglish
■85640▼uhttp://www.riss.kr/pdu/ddodLink.do?id=T16051309▼nKERIS▼z이 자료의 원문은 한국교육학술정보원에서 제공합니다.
■980 ▼a202202▼f2022


